|
Status |
Public on Apr 01, 2018 |
Title |
KRAS_G12D |
Sample type |
RNA |
|
|
Source name |
C2C12
|
Organism |
Mus musculus |
Characteristics |
days in differentiation media: 5
|
Treatment protocol |
Transduced cells were incubated in DMEM + 2% horse serum for 5 days prior to RNA extraction. Media was replaced daily.
|
Growth protocol |
C2C12 cells were transduced with retrovirus and selected with puromycin. Expression of RAS was verified by immunoblot.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using Qiagen RNeasy mini kit according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 250 ng total RNA
|
|
|
Hybridization protocol |
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on the Affymetrix mouse genome 430 2.0 array.
|
Scan protocol |
GeneChips were scanned according to standard protocols at the Genomics Technology Laboaratory
|
Description |
gene expression data from C2C12 myotubes
|
Data processing |
The data were normalized by Affymetrix Power Tool
|
|
|
Submission date |
Aug 03, 2016 |
Last update date |
Apr 01, 2018 |
Contact name |
Javed Khan |
E-mail(s) |
khanjav@mail.nih.gov
|
Phone |
2407606135
|
Organization name |
NCI, NIH
|
Department |
Genetics Branch
|
Lab |
Javed Khan
|
Street address |
37 Convent Dr.
|
City |
Bethesda |
State/province |
MD |
ZIP/Postal code |
20892 |
Country |
USA |
|
|
Platform ID |
GPL1261 |
Series (2) |
GSE85168 |
Oncogenic RAS blocks myogenic differentiation |
GSE85171 |
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition |
|